世界のアルファ-アンチトリプシン欠乏症治療市場規模・現状・予測（2021年-2027年）

• 英文タイトル：Global Alpha- Antitrypsin Deficiency Treatment Market Size, Status and Forecast 2021-2027

• レポートコード：QYR2104Z0255
• 出版社/出版日：QYResearch / 2021年4月
※2025年版があります。お問い合わせください。
• レポート形態：英文、PDF、133ページ
• 納品方法：Eメール（納期：3日）
• 産業分類：医療

• 販売価格（消費税別）

Single User	￥546,000 (USD3,900)	▷ お問い合わせ
Multi User/Five User	￥819,000 (USD5,850)	▷ お問い合わせ
Enterprise License（同一法人内共有可）	￥1,092,000 (USD7,800)	▷ お問い合わせ

• ご注文方法：お問い合わせフォーム記入又はEメールでご連絡ください。
• お支払方法：銀行振込（納品後、ご請求書送付）

レポート概要

QYResearch社発行の本調査資料では、アルファ-アンチトリプシン欠乏症治療のグローバル市場（2016年～2027年）について調べ、市場動向、主要企業の市場シェア、種類別市場規模（CT-2009、POL-6014、ARO-AAT、ALNAAT-02、その他）、用途別市場規模（クリニック、病院、その他）、主要地域別市場規模（北米、アメリカ、ヨーロッパ、アジア、日本、中国、韓国、インド、東南アジア、中南米、中東、アフリカ等）、関連企業情報などを掲載しています。
・市場概要
・アルファ-アンチトリプシン欠乏症治療の市場動向
・企業の競争状況、市場シェア
・アルファ-アンチトリプシン欠乏症治療の種類別市場規模（CT-2009、POL-6014、ARO-AAT、ALNAAT-02、その他）
・アルファ-アンチトリプシン欠乏症治療の用途別市場規模（クリニック、病院、その他）
・アルファ-アンチトリプシン欠乏症治療の北米市場規模2016-2027（アメリカ、カナダ）
・アルファ-アンチトリプシン欠乏症治療のヨーロッパ市場規模2016-2027（ドイツ、フランス、イギリス等）
・アルファ-アンチトリプシン欠乏症治療のアジア市場規模2016-2027（日本、中国、韓国、インド、東南アジア等）
・アルファ-アンチトリプシン欠乏症治療の中南米市場規模2016-2027（メキシコ、ブラジル）
・アルファ-アンチトリプシン欠乏症治療の中東・アフリカ市場規模2016-2027（トルコ、サウジアラビア等）
・主要企業情報（Adverum Biotechnologies, Inc.、Alnylam Pharmaceuticals, Inc.、Applied Genetic Technologies Corporation、Arrowhead Pharmaceuticals, Inc.、Carolus Therapeutics, Inc.、Cevec Pharmaceuticals GmbH、Dicerna Pharmaceuticals, Inc.、Digna Biotech, S.L.、Editas Medicine, Inc.、Grifols, S.A.、Inhibrx、Intellia Therapeutics, Inc.、International Stem Cell Corporation、Ionis Pharmaceuticals, Inc.、Kamada Ltd.、Polyphor Ltd.、ProMetic Life Sciences Inc.、rEVO Biologics, Inc.、Sangamo BioSciences, Inc.）
・結論

Market Analysis and Insights: Global Alpha- Antitrypsin Deficiency Treatment Market
The global Alpha- Antitrypsin Deficiency Treatment market size is projected to reach US$ XX million by 2026, from US$ XX million in 2019, at a CAGR of XX% during 2021-2026.
With industry-standard accuracy in analysis and high data integrity, the report makes a brilliant attempt to unveil key opportunities available in the global Alpha- Antitrypsin Deficiency Treatment market to help players in achieving a strong market position. Buyers of the report can access verified and reliable market forecasts, including those for the overall size of the global Alpha- Antitrypsin Deficiency Treatment market in terms of revenue.
On the whole, the report proves to be an effective tool that players can use to gain a competitive edge over their competitors and ensure lasting success in the global Alpha- Antitrypsin Deficiency Treatment market. All of the findings, data, and information provided in the report are validated and revalidated with the help of trustworthy sources. The analysts who have authored the report took a unique and industry-best research and analysis approach for an in-depth study of the global Alpha- Antitrypsin Deficiency Treatment market.

Global Alpha- Antitrypsin Deficiency Treatment Scope and Market Size
Alpha- Antitrypsin Deficiency Treatment market is segmented by company, region (country), by Type, and by Application. Players, stakeholders, and other participants in the global Alpha- Antitrypsin Deficiency Treatment market will be able to gain the upper hand as they use the report as a powerful resource. The segmental analysis focuses on revenue and forecast by Type and by Application in terms of revenue and forecast for the period 2016-2027.

Segment by Type
CT-2009
POL-6014
ARO-AAT
ALNAAT-02
Others

Segment by Application
Clinic
Hospital
Others

By Region
North America
U.S.
Canada
Europe
Germany
France
U.K.
Italy
Russia
Nordic
Rest of Europe
Asia-Pacific
China
Japan
South Korea
Southeast Asia
India
Australia
Rest of Asia
Latin America
Mexico
Brazil
Rest of Latin America
Middle East & Africa
Turkey
Saudi Arabia
UAE
Rest of MEA

By Company
Adverum Biotechnologies, Inc.
Alnylam Pharmaceuticals, Inc.
Applied Genetic Technologies Corporation
Arrowhead Pharmaceuticals, Inc.
Carolus Therapeutics, Inc.
Cevec Pharmaceuticals GmbH
Dicerna Pharmaceuticals, Inc.
Digna Biotech, S.L.
Editas Medicine, Inc.
Arrowhead Pharmaceuticals, Inc.
Carolus Therapeutics, Inc.
Intellia Therapeutics, Inc.
International Stem Cell Corporation
Ionis Pharmaceuticals, Inc.
Kamada Ltd.
Polyphor Ltd.
ProMetic Life Sciences Inc.

レポート目次

1 Report Overview
1.1 Study Scope
1.2 Market Analysis by Type
1.2.1 Global Alpha- Antitrypsin Deficiency Treatment Market Size Growth Rate by Type: 2016 VS 2021 VS 2027
1.2.2 CT-2009
1.2.3 POL-6014
1.2.4 ARO-AAT
1.2.5 ALNAAT-02
1.2.6 Others
1.3 Market by Application
1.3.1 Global Alpha- Antitrypsin Deficiency Treatment Market Share by Application: 2016 VS 2021 VS 2027
1.3.2 Clinic
1.3.3 Hospital
1.3.4 Others
1.4 Study Objectives
1.5 Years Considered

2 Global Growth Trends
2.1 Global Alpha- Antitrypsin Deficiency Treatment Market Perspective (2016-2027)
2.2 Alpha- Antitrypsin Deficiency Treatment Growth Trends by Regions
2.2.1 Alpha- Antitrypsin Deficiency Treatment Market Size by Regions: 2016 VS 2021 VS 2027
2.2.2 Alpha- Antitrypsin Deficiency Treatment Historic Market Share by Regions (2016-2021)
2.2.3 Alpha- Antitrypsin Deficiency Treatment Forecasted Market Size by Regions (2022-2027)
2.3 Alpha- Antitrypsin Deficiency Treatment Industry Dynamic
2.3.1 Alpha- Antitrypsin Deficiency Treatment Market Trends
2.3.2 Alpha- Antitrypsin Deficiency Treatment Market Drivers
2.3.3 Alpha- Antitrypsin Deficiency Treatment Market Challenges
2.3.4 Alpha- Antitrypsin Deficiency Treatment Market Restraints

3 Competition Landscape by Key Players
3.1 Global Top Alpha- Antitrypsin Deficiency Treatment Players by Revenue
3.1.1 Global Top Alpha- Antitrypsin Deficiency Treatment Players by Revenue (2016-2021)
3.1.2 Global Alpha- Antitrypsin Deficiency Treatment Revenue Market Share by Players (2016-2021)
3.2 Global Alpha- Antitrypsin Deficiency Treatment Market Share by Company Type (Tier 1, Tier 2 and Tier 3)
3.3 Players Covered: Ranking by Alpha- Antitrypsin Deficiency Treatment Revenue
3.4 Global Alpha- Antitrypsin Deficiency Treatment Market Concentration Ratio
3.4.1 Global Alpha- Antitrypsin Deficiency Treatment Market Concentration Ratio (CR5 and HHI)
3.4.2 Global Top 10 and Top 5 Companies by Alpha- Antitrypsin Deficiency Treatment Revenue in 2020
3.5 Alpha- Antitrypsin Deficiency Treatment Key Players Head office and Area Served
3.6 Key Players Alpha- Antitrypsin Deficiency Treatment Product Solution and Service
3.7 Date of Enter into Alpha- Antitrypsin Deficiency Treatment Market
3.8 Mergers & Acquisitions, Expansion Plans

4 Alpha- Antitrypsin Deficiency Treatment Breakdown Data by Type
4.1 Global Alpha- Antitrypsin Deficiency Treatment Historic Market Size by Type (2016-2021)
4.2 Global Alpha- Antitrypsin Deficiency Treatment Forecasted Market Size by Type (2022-2027)

5 Alpha- Antitrypsin Deficiency Treatment Breakdown Data by Application
5.1 Global Alpha- Antitrypsin Deficiency Treatment Historic Market Size by Application (2016-2021)
5.2 Global Alpha- Antitrypsin Deficiency Treatment Forecasted Market Size by Application (2022-2027)

6 North America
6.1 North America Alpha- Antitrypsin Deficiency Treatment Market Size (2016-2027)
6.2 North America Alpha- Antitrypsin Deficiency Treatment Market Size by Type
6.2.1 North America Alpha- Antitrypsin Deficiency Treatment Market Size by Type (2016-2021)
6.2.2 North America Alpha- Antitrypsin Deficiency Treatment Market Size by Type (2022-2027)
6.2.3 North America Alpha- Antitrypsin Deficiency Treatment Market Size by Type (2016-2027)
6.3 North America Alpha- Antitrypsin Deficiency Treatment Market Size by Application
6.3.1 North America Alpha- Antitrypsin Deficiency Treatment Market Size by Application (2016-2021)
6.3.2 North America Alpha- Antitrypsin Deficiency Treatment Market Size by Application (2022-2027)
6.3.3 North America Alpha- Antitrypsin Deficiency Treatment Market Size by Application (2016-2027)
6.4 North America Alpha- Antitrypsin Deficiency Treatment Market Size by Country
6.4.1 North America Alpha- Antitrypsin Deficiency Treatment Market Size by Country (2016-2021)
6.4.2 North America Alpha- Antitrypsin Deficiency Treatment Market Size by Country (2022-2027)
6.4.3 United States
6.4.3 Canada

7 Europe
7.1 Europe Alpha- Antitrypsin Deficiency Treatment Market Size (2016-2027)
7.2 Europe Alpha- Antitrypsin Deficiency Treatment Market Size by Type
7.2.1 Europe Alpha- Antitrypsin Deficiency Treatment Market Size by Type (2016-2021)
7.2.2 Europe Alpha- Antitrypsin Deficiency Treatment Market Size by Type (2022-2027)
7.2.3 Europe Alpha- Antitrypsin Deficiency Treatment Market Size by Type (2016-2027)
7.3 Europe Alpha- Antitrypsin Deficiency Treatment Market Size by Application
7.3.1 Europe Alpha- Antitrypsin Deficiency Treatment Market Size by Application (2016-2021)
7.3.2 Europe Alpha- Antitrypsin Deficiency Treatment Market Size by Application (2022-2027)
7.3.3 Europe Alpha- Antitrypsin Deficiency Treatment Market Size by Application (2016-2027)
7.4 Europe Alpha- Antitrypsin Deficiency Treatment Market Size by Country
7.4.1 Europe Alpha- Antitrypsin Deficiency Treatment Market Size by Country (2016-2021)
7.4.2 Europe Alpha- Antitrypsin Deficiency Treatment Market Size by Country (2022-2027)
7.4.3 Germany
7.4.4 France
7.4.5 U.K.
7.4.6 Italy
7.4.7 Russia
7.4.8 Nordic

8 Asia-Pacific
8.1 Asia-Pacific Alpha- Antitrypsin Deficiency Treatment Market Size (2016-2027)
8.2 Asia-Pacific Alpha- Antitrypsin Deficiency Treatment Market Size by Type
8.2.1 Asia-Pacific Alpha- Antitrypsin Deficiency Treatment Market Size by Type (2016-2021)
8.2.2 Asia-Pacific Alpha- Antitrypsin Deficiency Treatment Market Size by Type (2022-2027)
8.2.3 Asia-Pacific Alpha- Antitrypsin Deficiency Treatment Market Size by Type (2016-2027)
8.3 Asia-Pacific Alpha- Antitrypsin Deficiency Treatment Market Size by Application
8.3.1 Asia-Pacific Alpha- Antitrypsin Deficiency Treatment Market Size by Application (2016-2021)
8.3.2 Asia-Pacific Alpha- Antitrypsin Deficiency Treatment Market Size by Application (2022-2027)
8.3.3 Asia-Pacific Alpha- Antitrypsin Deficiency Treatment Market Size by Application (2016-2027)
8.4 Asia-Pacific Alpha- Antitrypsin Deficiency Treatment Market Size by Region
8.4.1 Asia-Pacific Alpha- Antitrypsin Deficiency Treatment Market Size by Region (2016-2021)
8.4.2 Asia-Pacific Alpha- Antitrypsin Deficiency Treatment Market Size by Region (2022-2027)
8.4.3 China
8.4.4 Japan
8.4.5 South Korea
8.4.6 Southeast Asia
8.4.7 India
8.4.8 Australia

9 Latin America
9.1 Latin America Alpha- Antitrypsin Deficiency Treatment Market Size (2016-2027)
9.2 Latin America Alpha- Antitrypsin Deficiency Treatment Market Size by Type
9.2.1 Latin America Alpha- Antitrypsin Deficiency Treatment Market Size by Type (2016-2021)
9.2.2 Latin America Alpha- Antitrypsin Deficiency Treatment Market Size by Type (2022-2027)
9.2.3 Latin America Alpha- Antitrypsin Deficiency Treatment Market Size by Type (2016-2027)
9.3 Latin America Alpha- Antitrypsin Deficiency Treatment Market Size by Application
9.3.1 Latin America Alpha- Antitrypsin Deficiency Treatment Market Size by Application (2016-2021)
9.3.2 Latin America Alpha- Antitrypsin Deficiency Treatment Market Size by Application (2022-2027)
9.3.3 Latin America Alpha- Antitrypsin Deficiency Treatment Market Size by Application (2016-2027)
9.4 Latin America Alpha- Antitrypsin Deficiency Treatment Market Size by Country
9.4.1 Latin America Alpha- Antitrypsin Deficiency Treatment Market Size by Country (2016-2021)
9.4.2 Latin America Alpha- Antitrypsin Deficiency Treatment Market Size by Country (2022-2027)
9.4.3 Mexico
9.4.4 Brazil

10 Middle East & Africa
10.1 Middle East & Africa Alpha- Antitrypsin Deficiency Treatment Market Size (2016-2027)
10.2 Middle East & Africa Alpha- Antitrypsin Deficiency Treatment Market Size by Type
10.2.1 Middle East & Africa Alpha- Antitrypsin Deficiency Treatment Market Size by Type (2016-2021)
10.2.2 Middle East & Africa Alpha- Antitrypsin Deficiency Treatment Market Size by Type (2022-2027)
10.2.3 Middle East & Africa Alpha- Antitrypsin Deficiency Treatment Market Size by Type (2016-2027)
10.3 Middle East & Africa Alpha- Antitrypsin Deficiency Treatment Market Size by Application
10.3.1 Middle East & Africa Alpha- Antitrypsin Deficiency Treatment Market Size by Application (2016-2021)
10.3.2 Middle East & Africa Alpha- Antitrypsin Deficiency Treatment Market Size by Application (2022-2027)
10.3.3 Middle East & Africa Alpha- Antitrypsin Deficiency Treatment Market Size by Application (2016-2027)
10.4 Middle East & Africa Alpha- Antitrypsin Deficiency Treatment Market Size by Country
10.4.1 Middle East & Africa Alpha- Antitrypsin Deficiency Treatment Market Size by Country (2016-2021)
10.4.2 Middle East & Africa Alpha- Antitrypsin Deficiency Treatment Market Size by Country (2022-2027)
10.4.3 Turkey
10.4.4 Saudi Arabia
10.4.5 UAE

11 Key Players Profiles
11.1 Adverum Biotechnologies, Inc.
11.1.1 Adverum Biotechnologies, Inc. Company Details
11.1.2 Adverum Biotechnologies, Inc. Business Overview
11.1.3 Adverum Biotechnologies, Inc. Alpha- Antitrypsin Deficiency Treatment Introduction
11.1.4 Adverum Biotechnologies, Inc. Revenue in Alpha- Antitrypsin Deficiency Treatment Business (2016-2021)
11.1.5 Adverum Biotechnologies, Inc. Recent Development
11.2 Alnylam Pharmaceuticals, Inc.
11.2.1 Alnylam Pharmaceuticals, Inc. Company Details
11.2.2 Alnylam Pharmaceuticals, Inc. Business Overview
11.2.3 Alnylam Pharmaceuticals, Inc. Alpha- Antitrypsin Deficiency Treatment Introduction
11.2.4 Alnylam Pharmaceuticals, Inc. Revenue in Alpha- Antitrypsin Deficiency Treatment Business (2016-2021)
11.2.5 Alnylam Pharmaceuticals, Inc. Recent Development
11.3 Applied Genetic Technologies Corporation
11.3.1 Applied Genetic Technologies Corporation Company Details
11.3.2 Applied Genetic Technologies Corporation Business Overview
11.3.3 Applied Genetic Technologies Corporation Alpha- Antitrypsin Deficiency Treatment Introduction
11.3.4 Applied Genetic Technologies Corporation Revenue in Alpha- Antitrypsin Deficiency Treatment Business (2016-2021)
11.3.5 Applied Genetic Technologies Corporation Recent Development
11.4 Arrowhead Pharmaceuticals, Inc.
11.4.1 Arrowhead Pharmaceuticals, Inc. Company Details
11.4.2 Arrowhead Pharmaceuticals, Inc. Business Overview
11.4.3 Arrowhead Pharmaceuticals, Inc. Alpha- Antitrypsin Deficiency Treatment Introduction
11.4.4 Arrowhead Pharmaceuticals, Inc. Revenue in Alpha- Antitrypsin Deficiency Treatment Business (2016-2021)
11.4.5 Arrowhead Pharmaceuticals, Inc. Recent Development
11.5 Carolus Therapeutics, Inc.
11.5.1 Carolus Therapeutics, Inc. Company Details
11.5.2 Carolus Therapeutics, Inc. Business Overview
11.5.3 Carolus Therapeutics, Inc. Alpha- Antitrypsin Deficiency Treatment Introduction
11.5.4 Carolus Therapeutics, Inc. Revenue in Alpha- Antitrypsin Deficiency Treatment Business (2016-2021)
11.5.5 Carolus Therapeutics, Inc. Recent Development
11.6 Cevec Pharmaceuticals GmbH
11.6.1 Cevec Pharmaceuticals GmbH Company Details
11.6.2 Cevec Pharmaceuticals GmbH Business Overview
11.6.3 Cevec Pharmaceuticals GmbH Alpha- Antitrypsin Deficiency Treatment Introduction
11.6.4 Cevec Pharmaceuticals GmbH Revenue in Alpha- Antitrypsin Deficiency Treatment Business (2016-2021)
11.6.5 Cevec Pharmaceuticals GmbH Recent Development
11.7 Dicerna Pharmaceuticals, Inc.
11.7.1 Dicerna Pharmaceuticals, Inc. Company Details
11.7.2 Dicerna Pharmaceuticals, Inc. Business Overview
11.7.3 Dicerna Pharmaceuticals, Inc. Alpha- Antitrypsin Deficiency Treatment Introduction
11.7.4 Dicerna Pharmaceuticals, Inc. Revenue in Alpha- Antitrypsin Deficiency Treatment Business (2016-2021)
11.7.5 Dicerna Pharmaceuticals, Inc. Recent Development
11.8 Digna Biotech, S.L.
11.8.1 Digna Biotech, S.L. Company Details
11.8.2 Digna Biotech, S.L. Business Overview
11.8.3 Digna Biotech, S.L. Alpha- Antitrypsin Deficiency Treatment Introduction
11.8.4 Digna Biotech, S.L. Revenue in Alpha- Antitrypsin Deficiency Treatment Business (2016-2021)
11.8.5 Digna Biotech, S.L. Recent Development
11.9 Editas Medicine, Inc.
11.9.1 Editas Medicine, Inc. Company Details
11.9.2 Editas Medicine, Inc. Business Overview
11.9.3 Editas Medicine, Inc. Alpha- Antitrypsin Deficiency Treatment Introduction
11.9.4 Editas Medicine, Inc. Revenue in Alpha- Antitrypsin Deficiency Treatment Business (2016-2021)
11.9.5 Editas Medicine, Inc. Recent Development
11.10 Grifols, S.A.
11.10.1 Grifols, S.A. Company Details
11.10.2 Grifols, S.A. Business Overview
11.10.3 Grifols, S.A. Alpha- Antitrypsin Deficiency Treatment Introduction
11.10.4 Grifols, S.A. Revenue in Alpha- Antitrypsin Deficiency Treatment Business (2016-2021)
11.10.5 Grifols, S.A. Recent Development
11.11 Inhibrx
11.11.1 Inhibrx Company Details
11.11.2 Inhibrx Business Overview
11.11.3 Inhibrx Alpha- Antitrypsin Deficiency Treatment Introduction
11.11.4 Inhibrx Revenue in Alpha- Antitrypsin Deficiency Treatment Business (2016-2021)
11.11.5 Inhibrx Recent Development
11.12 Intellia Therapeutics, Inc.
11.12.1 Intellia Therapeutics, Inc. Company Details
11.12.2 Intellia Therapeutics, Inc. Business Overview
11.12.3 Intellia Therapeutics, Inc. Alpha- Antitrypsin Deficiency Treatment Introduction
11.12.4 Intellia Therapeutics, Inc. Revenue in Alpha- Antitrypsin Deficiency Treatment Business (2016-2021)
11.12.5 Intellia Therapeutics, Inc. Recent Development
11.13 International Stem Cell Corporation
11.13.1 International Stem Cell Corporation Company Details
11.13.2 International Stem Cell Corporation Business Overview
11.13.3 International Stem Cell Corporation Alpha- Antitrypsin Deficiency Treatment Introduction
11.13.4 International Stem Cell Corporation Revenue in Alpha- Antitrypsin Deficiency Treatment Business (2016-2021)
11.13.5 International Stem Cell Corporation Recent Development
11.14 Ionis Pharmaceuticals, Inc.
11.14.1 Ionis Pharmaceuticals, Inc. Company Details
11.14.2 Ionis Pharmaceuticals, Inc. Business Overview
11.14.3 Ionis Pharmaceuticals, Inc. Alpha- Antitrypsin Deficiency Treatment Introduction
11.14.4 Ionis Pharmaceuticals, Inc. Revenue in Alpha- Antitrypsin Deficiency Treatment Business (2016-2021)
11.14.5 Ionis Pharmaceuticals, Inc. Recent Development
11.15 Kamada Ltd.
11.15.1 Kamada Ltd. Company Details
11.15.2 Kamada Ltd. Business Overview
11.15.3 Kamada Ltd. Alpha- Antitrypsin Deficiency Treatment Introduction
11.15.4 Kamada Ltd. Revenue in Alpha- Antitrypsin Deficiency Treatment Business (2016-2021)
11.15.5 Kamada Ltd. Recent Development
11.16 Polyphor Ltd.
11.16.1 Polyphor Ltd. Company Details
11.16.2 Polyphor Ltd. Business Overview
11.16.3 Polyphor Ltd. Alpha- Antitrypsin Deficiency Treatment Introduction
11.16.4 Polyphor Ltd. Revenue in Alpha- Antitrypsin Deficiency Treatment Business (2016-2021)
11.16.5 Polyphor Ltd. Recent Development
11.17 ProMetic Life Sciences Inc.
11.17.1 ProMetic Life Sciences Inc. Company Details
11.17.2 ProMetic Life Sciences Inc. Business Overview
11.17.3 ProMetic Life Sciences Inc. Alpha- Antitrypsin Deficiency Treatment Introduction
11.17.4 ProMetic Life Sciences Inc. Revenue in Alpha- Antitrypsin Deficiency Treatment Business (2016-2021)
11.17.5 ProMetic Life Sciences Inc. Recent Development
11.18 rEVO Biologics, Inc.
11.18.1 rEVO Biologics, Inc. Company Details
11.18.2 rEVO Biologics, Inc. Business Overview
11.18.3 rEVO Biologics, Inc. Alpha- Antitrypsin Deficiency Treatment Introduction
11.18.4 rEVO Biologics, Inc. Revenue in Alpha- Antitrypsin Deficiency Treatment Business (2016-2021)
11.18.5 rEVO Biologics, Inc. Recent Development
11.18 Sangamo BioSciences, Inc.
.1 Sangamo BioSciences, Inc. Company Details
.2 Sangamo BioSciences, Inc. Business Overview
.3 Sangamo BioSciences, Inc. Alpha- Antitrypsin Deficiency Treatment Introduction
.4 Sangamo BioSciences, Inc. Revenue in Alpha- Antitrypsin Deficiency Treatment Business (2016-2021)
.5 Sangamo BioSciences, Inc. Recent Development

12 Analyst’s Viewpoints/Conclusions

13 Appendix
13.1 Research Methodology
13.1.1 Methodology/Research Approach
13.1.2 Data Source
13.2 Disclaimer
13.3 Author Details

List of Tables
Table 1. Global Alpha- Antitrypsin Deficiency Treatment Market Size Growth Rate by Type (US$ Million):2016 VS 2021 VS 2027
Table 2. Key Players of CT-2009
Table 3. Key Players of POL-6014
Table 4. Key Players of ARO-AAT
Table 5. Key Players of ALNAAT-02
Table 6. Key Players of Others
Table 7. Global Alpha- Antitrypsin Deficiency Treatment Market Size Growth by Application (US$ Million): 2016 VS 2021 VS 2027
Table 8. Global Alpha- Antitrypsin Deficiency Treatment Market Size by Regions (US$ Million): 2016 VS 2021 VS 2027
Table 9. Global Alpha- Antitrypsin Deficiency Treatment Market Size by Regions (2016-2021) & (US$ Million)
Table 10. Global Alpha- Antitrypsin Deficiency Treatment Market Share by Regions (2016-2021)
Table 11. Global Alpha- Antitrypsin Deficiency Treatment Forecasted Market Size by Regions (2022-2027) & (US$ Million)
Table 12. Global Alpha- Antitrypsin Deficiency Treatment Market Share by Regions (2022-2027)
Table 13. Alpha- Antitrypsin Deficiency Treatment Market Trends
Table 14. Alpha- Antitrypsin Deficiency Treatment Market Drivers
Table 15. Alpha- Antitrypsin Deficiency Treatment Market Challenges
Table 16. Alpha- Antitrypsin Deficiency Treatment Market Restraints
Table 17. Global Alpha- Antitrypsin Deficiency Treatment Revenue by Players (2016-2021) & (US$ Million)
Table 18. Global Alpha- Antitrypsin Deficiency Treatment Market Share by Players (2016-2021)
Table 19. Global Top Alpha- Antitrypsin Deficiency Treatment Players by Company Type (Tier 1, Tier 2 and Tier 3) (based on the Revenue in Alpha- Antitrypsin Deficiency Treatment as of 2020)
Table 20. Ranking of Global Top Alpha- Antitrypsin Deficiency Treatment Companies by Revenue (US$ Million) in 2020
Table 21. Global 5 Largest Players Market Share by Alpha- Antitrypsin Deficiency Treatment Revenue (CR5 and HHI) & (2016-2021)
Table 22. Key Players Headquarters and Area Served
Table 23. Key Players Alpha- Antitrypsin Deficiency Treatment Product Solution and Service
Table 24. Date of Enter into Alpha- Antitrypsin Deficiency Treatment Market
Table 25. Mergers & Acquisitions, Expansion Plans
Table 26. Global Alpha- Antitrypsin Deficiency Treatment Market Size by Type (2016-2021) (US$ Million)
Table 27. Global Alpha- Antitrypsin Deficiency Treatment Revenue Market Share by Type (2016-2021)
Table 28. Global Alpha- Antitrypsin Deficiency Treatment Forecasted Market Size by Type (2022-2027) (US$ Million)
Table 29. Global Alpha- Antitrypsin Deficiency Treatment Revenue Market Share by Type (2022-2027) & (US$ Million)
Table 30. Global Alpha- Antitrypsin Deficiency Treatment Market Size Share by Application (2016-2021) & (US$ Million)
Table 31. Global Alpha- Antitrypsin Deficiency Treatment Revenue Market Share by Application (2016-2021)
Table 32. Global Alpha- Antitrypsin Deficiency Treatment Forecasted Market Size by Application (2022-2027) (US$ Million)
Table 33. Global Alpha- Antitrypsin Deficiency Treatment Revenue Market Share by Application (2022-2027) & (US$ Million)
Table 34. North America Alpha- Antitrypsin Deficiency Treatment Market Size by Type (2016-2021) (US$ Million)
Table 35. North America Alpha- Antitrypsin Deficiency Treatment Market Size by Type (2022-2027) & (US$ Million)
Table 36. North America Alpha- Antitrypsin Deficiency Treatment Market Size by Application (2016-2021) (US$ Million)
Table 37. North America Alpha- Antitrypsin Deficiency Treatment Market Size by Application (2022-2027) & (US$ Million)
Table 38. North America Alpha- Antitrypsin Deficiency Treatment Market Size by Country (2016-2021) & (US$ Million)
Table 39. North America Alpha- Antitrypsin Deficiency Treatment Market Size by Country (2022-2027) & (US$ Million)
Table 40. Europe Alpha- Antitrypsin Deficiency Treatment Market Size by Type (2016-2021) (US$ Million)
Table 41. Europe Alpha- Antitrypsin Deficiency Treatment Market Size by Type (2022-2027) & (US$ Million)
Table 42. Europe Alpha- Antitrypsin Deficiency Treatment Market Size by Application (2016-2021) (US$ Million)
Table 43. Europe Alpha- Antitrypsin Deficiency Treatment Market Size by Application (2022-2027) & (US$ Million)
Table 44. Europe Alpha- Antitrypsin Deficiency Treatment Market Size by Country (2016-2021) & (US$ Million)
Table 45. Europe Alpha- Antitrypsin Deficiency Treatment Market Size by Country (2022-2027) & (US$ Million)
Table 46. Asia-Pacific Alpha- Antitrypsin Deficiency Treatment Market Size by Type (2016-2021) (US$ Million)
Table 47. Asia-Pacific Alpha- Antitrypsin Deficiency Treatment Market Size by Type (2022-2027) & (US$ Million)
Table 48. Asia-Pacific Alpha- Antitrypsin Deficiency Treatment Market Size by Application (2016-2021) (US$ Million)
Table 49. Asia-Pacific Alpha- Antitrypsin Deficiency Treatment Market Size by Application (2022-2027) & (US$ Million)
Table 50. Asia-Pacific Alpha- Antitrypsin Deficiency Treatment Market Size by Region (2016-2021) & (US$ Million)
Table 51. Asia-Pacific Alpha- Antitrypsin Deficiency Treatment Market Size by Region (2022-2027) & (US$ Million)
Table 52. Latin America Alpha- Antitrypsin Deficiency Treatment Market Size by Type (2016-2021) (US$ Million)
Table 53. Latin America Alpha- Antitrypsin Deficiency Treatment Market Size by Type (2022-2027) & (US$ Million)
Table 54. Latin America Alpha- Antitrypsin Deficiency Treatment Market Size by Application (2016-2021) (US$ Million)
Table 55. Latin America Alpha- Antitrypsin Deficiency Treatment Market Size by Application (2022-2027) & (US$ Million)
Table 56. Latin America Alpha- Antitrypsin Deficiency Treatment Market Size by Country (2016-2021) & (US$ Million)
Table 57. Latin America Alpha- Antitrypsin Deficiency Treatment Market Size by Country (2022-2027) & (US$ Million)
Table 58. Middle East & Africa Alpha- Antitrypsin Deficiency Treatment Market Size by Type (2016-2021) (US$ Million)
Table 59. Middle East & Africa Alpha- Antitrypsin Deficiency Treatment Market Size by Type (2022-2027) & (US$ Million)
Table 60. Middle East & Africa Alpha- Antitrypsin Deficiency Treatment Market Size by Application (2016-2021) (US$ Million)
Table 61. Middle East & Africa Alpha- Antitrypsin Deficiency Treatment Market Size by Application (2022-2027) & (US$ Million)
Table 62. Middle East & Africa Alpha- Antitrypsin Deficiency Treatment Market Size by Country (2016-2021) & (US$ Million)
Table 63. Middle East & Africa Alpha- Antitrypsin Deficiency Treatment Market Size by Country (2022-2027) & (US$ Million)
Table 64. Adverum Biotechnologies, Inc. Company Details
Table 65. Adverum Biotechnologies, Inc. Business Overview
Table 66. Adverum Biotechnologies, Inc. Alpha- Antitrypsin Deficiency Treatment Product
Table 67. Adverum Biotechnologies, Inc. Revenue in Alpha- Antitrypsin Deficiency Treatment Business (2016-2021) & (US$ Million)
Table 68. Adverum Biotechnologies, Inc. Recent Development
Table 69. Alnylam Pharmaceuticals, Inc. Company Details
Table 70. Alnylam Pharmaceuticals, Inc. Business Overview
Table 71. Alnylam Pharmaceuticals, Inc. Alpha- Antitrypsin Deficiency Treatment Product
Table 72. Alnylam Pharmaceuticals, Inc. Revenue in Alpha- Antitrypsin Deficiency Treatment Business (2016-2021) & (US$ Million)
Table 73. Alnylam Pharmaceuticals, Inc. Recent Development
Table 74. Applied Genetic Technologies Corporation Company Details
Table 75. Applied Genetic Technologies Corporation Business Overview
Table 76. Applied Genetic Technologies Corporation Alpha- Antitrypsin Deficiency Treatment Product
Table 77. Applied Genetic Technologies Corporation Revenue in Alpha- Antitrypsin Deficiency Treatment Business (2016-2021) & (US$ Million)
Table 78. Applied Genetic Technologies Corporation Recent Development
Table 79. Arrowhead Pharmaceuticals, Inc. Company Details
Table 80. Arrowhead Pharmaceuticals, Inc. Business Overview
Table 81. Arrowhead Pharmaceuticals, Inc. Alpha- Antitrypsin Deficiency Treatment Product
Table 82. Arrowhead Pharmaceuticals, Inc. Revenue in Alpha- Antitrypsin Deficiency Treatment Business (2016-2021) & (US$ Million)
Table 83. Arrowhead Pharmaceuticals, Inc. Recent Development
Table 84. Carolus Therapeutics, Inc. Company Details
Table 85. Carolus Therapeutics, Inc. Business Overview
Table 86. Carolus Therapeutics, Inc. Alpha- Antitrypsin Deficiency Treatment Product
Table 87. Carolus Therapeutics, Inc. Revenue in Alpha- Antitrypsin Deficiency Treatment Business (2016-2021) & (US$ Million)
Table 88. Carolus Therapeutics, Inc. Recent Development
Table 89. Cevec Pharmaceuticals GmbH Company Details
Table 90. Cevec Pharmaceuticals GmbH Business Overview
Table 91. Cevec Pharmaceuticals GmbH Alpha- Antitrypsin Deficiency Treatment Product
Table 92. Cevec Pharmaceuticals GmbH Revenue in Alpha- Antitrypsin Deficiency Treatment Business (2016-2021) & (US$ Million)
Table 93. Cevec Pharmaceuticals GmbH Recent Development
Table 94. Dicerna Pharmaceuticals, Inc. Company Details
Table 95. Dicerna Pharmaceuticals, Inc. Business Overview
Table 96. Dicerna Pharmaceuticals, Inc. Alpha- Antitrypsin Deficiency Treatment Product
Table 97. Dicerna Pharmaceuticals, Inc. Revenue in Alpha- Antitrypsin Deficiency Treatment Business (2016-2021) & (US$ Million)
Table 98. Dicerna Pharmaceuticals, Inc. Recent Development
Table 99. Digna Biotech, S.L. Company Details
Table 100. Digna Biotech, S.L. Business Overview
Table 101. Digna Biotech, S.L. Revenue in Alpha- Antitrypsin Deficiency Treatment Business (2016-2021) & (US$ Million)
Table 102. Digna Biotech, S.L. Recent Development
Table 103. Editas Medicine, Inc. Company Details
Table 104. Editas Medicine, Inc. Business Overview
Table 105. Editas Medicine, Inc. Alpha- Antitrypsin Deficiency Treatment Product
Table 106. Editas Medicine, Inc. Revenue in Alpha- Antitrypsin Deficiency Treatment Business (2016-2021) & (US$ Million)
Table 107. Editas Medicine, Inc. Recent Development
Table 108. Grifols, S.A. Company Details
Table 109. Grifols, S.A. Business Overview
Table 110. Grifols, S.A. Alpha- Antitrypsin Deficiency Treatment Product
Table 111. Grifols, S.A. Revenue in Alpha- Antitrypsin Deficiency Treatment Business (2016-2021) & (US$ Million)
Table 112. Grifols, S.A. Recent Development
Table 113. Inhibrx Company Details
Table 114. Inhibrx Business Overview
Table 115. Inhibrx Alpha- Antitrypsin Deficiency Treatment Product
Table 116. Inhibrx Revenue in Alpha- Antitrypsin Deficiency Treatment Business (2016-2021) & (US$ Million)
Table 117. Inhibrx Recent Development
Table 118. Intellia Therapeutics, Inc. Company Details
Table 119. Intellia Therapeutics, Inc. Business Overview
Table 120. Intellia Therapeutics, Inc. Alpha- Antitrypsin Deficiency Treatment Product
Table 121. Intellia Therapeutics, Inc. Revenue in Alpha- Antitrypsin Deficiency Treatment Business (2016-2021) & (US$ Million)
Table 122. Intellia Therapeutics, Inc. Recent Development
Table 123. International Stem Cell Corporation Company Details
Table 124. International Stem Cell Corporation Business Overview
Table 125. International Stem Cell Corporation Alpha- Antitrypsin Deficiency Treatment Product
Table 126. International Stem Cell Corporation Revenue in Alpha- Antitrypsin Deficiency Treatment Business (2016-2021) & (US$ Million)
Table 127. International Stem Cell Corporation Recent Development
Table 128. Ionis Pharmaceuticals, Inc. Company Details
Table 129. Ionis Pharmaceuticals, Inc. Business Overview
Table 130. Ionis Pharmaceuticals, Inc. Alpha- Antitrypsin Deficiency Treatment Product
Table 131. Ionis Pharmaceuticals, Inc. Revenue in Alpha- Antitrypsin Deficiency Treatment Business (2016-2021) & (US$ Million)
Table 132. Ionis Pharmaceuticals, Inc. Recent Development
Table 133. Kamada Ltd. Company Details
Table 134. Kamada Ltd. Business Overview
Table 135. Kamada Ltd. Alpha- Antitrypsin Deficiency Treatment Product
Table 136. Kamada Ltd. Revenue in Alpha- Antitrypsin Deficiency Treatment Business (2016-2021) & (US$ Million)
Table 137. Kamada Ltd. Recent Development
Table 138. Polyphor Ltd. Company Details
Table 139. Polyphor Ltd. Business Overview
Table 140. Polyphor Ltd. Alpha- Antitrypsin Deficiency Treatment Product
Table 141. Polyphor Ltd. Revenue in Alpha- Antitrypsin Deficiency Treatment Business (2016-2021) & (US$ Million)
Table 142. Polyphor Ltd. Recent Development
Table 143. ProMetic Life Sciences Inc. Company Details
Table 144. ProMetic Life Sciences Inc. Business Overview
Table 145. ProMetic Life Sciences Inc. Alpha- Antitrypsin Deficiency Treatment Product
Table 146. ProMetic Life Sciences Inc. Revenue in Alpha- Antitrypsin Deficiency Treatment Business (2016-2021) & (US$ Million)
Table 147. ProMetic Life Sciences Inc. Recent Development
Table 148. rEVO Biologics, Inc. Company Details
Table 149. rEVO Biologics, Inc. Business Overview
Table 150. rEVO Biologics, Inc. Alpha- Antitrypsin Deficiency Treatment Product
Table 151. rEVO Biologics, Inc. Revenue in Alpha- Antitrypsin Deficiency Treatment Business (2016-2021) & (US$ Million)
Table 152. rEVO Biologics, Inc. Recent Development
Table 153. Sangamo BioSciences, Inc. Company Details
Table 154. Sangamo BioSciences, Inc. Business Overview
Table 155. Sangamo BioSciences, Inc. Alpha- Antitrypsin Deficiency Treatment Product
Table 156. Sangamo BioSciences, Inc. Revenue in Alpha- Antitrypsin Deficiency Treatment Business (2016-2021) & (US$ Million)
Table 157. Sangamo BioSciences, Inc. Recent Development
Table 158. Research Programs/Design for This Report
Table 159. Key Data Information from Secondary Sources
Table 160. Key Data Information from Primary Sources
List of Figures
Figure 1. Global Alpha- Antitrypsin Deficiency Treatment Market Share by Type: 2020 VS 2027
Figure 2. CT-2009 Features
Figure 3. POL-6014 Features
Figure 4. ARO-AAT Features
Figure 5. ALNAAT-02 Features
Figure 6. Others Features
Figure 7. Global Alpha- Antitrypsin Deficiency Treatment Market Share by Application: 2020 VS 2027
Figure 8. Clinic Case Studies
Figure 9. Hospital Case Studies
Figure 10. Others Case Studies
Figure 11. Alpha- Antitrypsin Deficiency Treatment Report Years Considered
Figure 12. Global Alpha- Antitrypsin Deficiency Treatment Market Size (US$ Million), Year-over-Year: 2016-2027
Figure 13. Global Alpha- Antitrypsin Deficiency Treatment Market Size (US$ Million), 2016 VS 2021 VS 2027
Figure 14. Global Alpha- Antitrypsin Deficiency Treatment Market Share by Regions: 2020 VS 2027
Figure 15. Global Alpha- Antitrypsin Deficiency Treatment Market Share by Regions (2022-2027)
Figure 16. Global Alpha- Antitrypsin Deficiency Treatment Market Share by Players in 2020
Figure 17. Global Top Alpha- Antitrypsin Deficiency Treatment Players by Company Type (Tier 1, Tier 2 and Tier 3) (based on the Revenue in Alpha- Antitrypsin Deficiency Treatment as of 2020
Figure 18. The Top 10 and 5 Players Market Share by Alpha- Antitrypsin Deficiency Treatment Revenue in 2020
Figure 19. Global Alpha- Antitrypsin Deficiency Treatment Revenue Market Share by Type (2016-2021)
Figure 20. Global Alpha- Antitrypsin Deficiency Treatment Revenue Market Share by Type (2022-2027)
Figure 21. North America Alpha- Antitrypsin Deficiency Treatment Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 22. North America Alpha- Antitrypsin Deficiency Treatment Market Share by Type (2016-2027)
Figure 23. North America Alpha- Antitrypsin Deficiency Treatment Market Share by Application (2016-2027)
Figure 24. North America Alpha- Antitrypsin Deficiency Treatment Market Share by Country (2016-2027)
Figure 25. United States Alpha- Antitrypsin Deficiency Treatment Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 26. Canada Alpha- Antitrypsin Deficiency Treatment Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 27. Europe Alpha- Antitrypsin Deficiency Treatment Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 28. Europe Alpha- Antitrypsin Deficiency Treatment Market Share by Type (2016-2027)
Figure 29. Europe Alpha- Antitrypsin Deficiency Treatment Market Share by Application (2016-2027)
Figure 30. Europe Alpha- Antitrypsin Deficiency Treatment Market Share by Country (2016-2027)
Figure 31. Germany Alpha- Antitrypsin Deficiency Treatment Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 32. France Alpha- Antitrypsin Deficiency Treatment Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 33. U.K. Alpha- Antitrypsin Deficiency Treatment Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 34. Italy Alpha- Antitrypsin Deficiency Treatment Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 35. Russia Alpha- Antitrypsin Deficiency Treatment Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 36. Nordic Alpha- Antitrypsin Deficiency Treatment Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 37. Asia-Pacific Alpha- Antitrypsin Deficiency Treatment Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 38. Asia-Pacific Alpha- Antitrypsin Deficiency Treatment Market Share by Type (2016-2027)
Figure 39. Asia-Pacific Alpha- Antitrypsin Deficiency Treatment Market Share by Application (2016-2027)
Figure 40. Asia-Pacific Alpha- Antitrypsin Deficiency Treatment Market Share by Region (2016-2027)
Figure 41. China Alpha- Antitrypsin Deficiency Treatment Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 42. Japan Alpha- Antitrypsin Deficiency Treatment Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 43. South Korea Alpha- Antitrypsin Deficiency Treatment Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 44. Southeast Asia Alpha- Antitrypsin Deficiency Treatment Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 45. India Alpha- Antitrypsin Deficiency Treatment Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 46. Australia Alpha- Antitrypsin Deficiency Treatment Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 47. Latin America Alpha- Antitrypsin Deficiency Treatment Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 48. Latin America Alpha- Antitrypsin Deficiency Treatment Market Share by Type (2016-2027)
Figure 49. Latin America Alpha- Antitrypsin Deficiency Treatment Market Share by Application (2016-2027)
Figure 50. Latin America Alpha- Antitrypsin Deficiency Treatment Market Share by Country (2016-2027)
Figure 51. Mexico Alpha- Antitrypsin Deficiency Treatment Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 52. Brazil Alpha- Antitrypsin Deficiency Treatment Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 53. Middle East & Africa Alpha- Antitrypsin Deficiency Treatment Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 54. Middle East & Africa Alpha- Antitrypsin Deficiency Treatment Market Share by Type (2016-2027)
Figure 55. Middle East & Africa Alpha- Antitrypsin Deficiency Treatment Market Share by Application (2016-2027)
Figure 56. Middle East & Africa Alpha- Antitrypsin Deficiency Treatment Market Share by Country (2016-2027)
Figure 57. Turkey Alpha- Antitrypsin Deficiency Treatment Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 58. Saudi Arabia Alpha- Antitrypsin Deficiency Treatment Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 59. UAE Alpha- Antitrypsin Deficiency Treatment Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 60. Adverum Biotechnologies, Inc. Revenue Growth Rate in Alpha- Antitrypsin Deficiency Treatment Business (2016-2021)
Figure 61. Alnylam Pharmaceuticals, Inc. Revenue Growth Rate in Alpha- Antitrypsin Deficiency Treatment Business (2016-2021)
Figure 62. Applied Genetic Technologies Corporation Revenue Growth Rate in Alpha- Antitrypsin Deficiency Treatment Business (2016-2021)
Figure 63. Arrowhead Pharmaceuticals, Inc. Revenue Growth Rate in Alpha- Antitrypsin Deficiency Treatment Business (2016-2021)
Figure 64. Carolus Therapeutics, Inc. Revenue Growth Rate in Alpha- Antitrypsin Deficiency Treatment Business (2016-2021)
Figure 65. Cevec Pharmaceuticals GmbH Revenue Growth Rate in Alpha- Antitrypsin Deficiency Treatment Business (2016-2021)
Figure 66. Dicerna Pharmaceuticals, Inc. Revenue Growth Rate in Alpha- Antitrypsin Deficiency Treatment Business (2016-2021)
Figure 67. Digna Biotech, S.L. Revenue Growth Rate in Alpha- Antitrypsin Deficiency Treatment Business (2016-2021)
Figure 68. Editas Medicine, Inc. Revenue Growth Rate in Alpha- Antitrypsin Deficiency Treatment Business (2016-2021)
Figure 69. Grifols, S.A. Revenue Growth Rate in Alpha- Antitrypsin Deficiency Treatment Business (2016-2021)
Figure 70. Inhibrx Revenue Growth Rate in Alpha- Antitrypsin Deficiency Treatment Business (2016-2021)
Figure 71. Intellia Therapeutics, Inc. Revenue Growth Rate in Alpha- Antitrypsin Deficiency Treatment Business (2016-2021)
Figure 72. International Stem Cell Corporation Revenue Growth Rate in Alpha- Antitrypsin Deficiency Treatment Business (2016-2021)
Figure 73. Ionis Pharmaceuticals, Inc. Revenue Growth Rate in Alpha- Antitrypsin Deficiency Treatment Business (2016-2021)
Figure 74. Kamada Ltd. Revenue Growth Rate in Alpha- Antitrypsin Deficiency Treatment Business (2016-2021)
Figure 75. Polyphor Ltd. Revenue Growth Rate in Alpha- Antitrypsin Deficiency Treatment Business (2016-2021)
Figure 76. ProMetic Life Sciences Inc. Revenue Growth Rate in Alpha- Antitrypsin Deficiency Treatment Business (2016-2021)
Figure 77. rEVO Biologics, Inc. Revenue Growth Rate in Alpha- Antitrypsin Deficiency Treatment Business (2016-2021)
Figure 78. Sangamo BioSciences, Inc. Revenue Growth Rate in Alpha- Antitrypsin Deficiency Treatment Business (2016-2021)
Figure 79. Bottom-up and Top-down Approaches for This Report
Figure 80. Data Triangulation
Figure 81. Key Executives Interviewed

Global Alpha 1 Antitrypsin Deficiency Treatment Market 2021 by Company, Regions, Type and Application, Forecast to 2026
GIR-2104Z00720 2021年4月 128Pages
当調査資料では、α1-アンチトリプシン欠乏症治療のグローバル市場について調査・分析し、2021年から2026年までの市場予測をまとめております。α1-アンチトリプシン欠乏症治療の種類別市場規模（増強療法、気管支拡張薬、コルチコステロイド、酸素療法）、用途別市場規模（病院、専門診療所、薬局）、地域別市...

世界のアルファ-フェトプロテイン（AFP）検査市場規模・現状・予測（2021年-2027年）

Global Alpha-Fetaprotein Testing Market Size, Status and Forecast 2021-2027
QYR2104Z0259 2021年4月 131Pages
QYResearch社発行の本調査資料では、アルファ-フェトプロテイン（AFP）検査のグローバル市場（2016年～2027年）について調べ、市場動向、主要企業の市場シェア、種類別市場規模（イムノアッセイ、分子診断、染色体分析、その他）、用途別市場規模（研究センター、病院、クリニック、その他）、主要地...

世界のアルファ-フェトプロテイン（AFP）検査市場規模・現状・予測（2021年-2027年）

世界のビタミンD欠乏症治療市場規模・現状・予測（2021年-2027年）

Global Vitamin D Deficiency Treatment Market Size, Status and Forecast 2021-2027
QYR2104Z5957 2021年4月 92Pages
QYResearch社発行の本調査資料では、ビタミンD欠乏症治療のグローバル市場（2016年～2027年）について調べ、市場動向、主要企業の市場シェア、種類別市場規模（ビタミンD2、ビタミンD3）、用途別市場規模（病院、診療所、その他）、主要地域別市場規模（北米、アメリカ、ヨーロッパ、アジア、日本、...

世界のアデノシンデアミナーゼ欠損症（ADA）治療市場規模・現状・予測（2021年-2027年）

Global Adenosine Deaminase Deficiency Treatment Market Size, Status and Forecast 2021-2027
QYR2104Z0096 2021年4月 96Pages
QYResearch社発行の本調査資料では、アデノシンデアミナーゼ欠損症（ADA）治療のグローバル市場（2016年～2027年）について調べ、市場動向、主要企業の市場シェア、種類別市場規模（アダーゲン、レブコビ）、用途別市場規模（病院、薬局）、主要地域別市場規模（北米、アメリカ、ヨーロッパ、アジア、...

世界のチロシンヒドロキシラーゼ欠損症治療市場規模・現状・予測（2021年-2027年）

Global Tyrosine Hydroxylase Deficiency Treatment Market Size, Status and Forecast 2021-2027
QYR2104Z5773 2021年4月 91Pages
QYResearch社発行の本調査資料では、チロシンヒドロキシラーゼ欠損症治療のグローバル市場（2016年～2027年）について調べ、市場動向、主要企業の市場シェア、種類別市場規模（投薬、言語療法、その他）、用途別市場規模（病院、診療所、診断センター、その他）、主要地域別市場規模（北米、アメリカ、ヨ...

世界の第IX因子欠乏症治療市場規模・現状・予測（2021年-2027年）

Global Factor IX Deficiency Treatment Market Size, Status and Forecast 2021-2027
QYR2104Z2309 2021年4月 97Pages
QYResearch社発行の本調査資料では、第IX因子欠乏症治療のグローバル市場（2016年～2027年）について調べ、市場動向、主要企業の市場シェア、種類別市場規模（血友病B、血友病B阻害剤）、用途別市場規模（病院、クリニック、その他）、主要地域別市場規模（北米、アメリカ、ヨーロッパ、アジア、日本...

世界の成長ホルモン欠乏症治療市場規模・現状・予測（2021年-2027年）

Global Growth Hormone Deficiency Treatment Market Size, Status and Forecast 2021-2027
QYR2104Z2639 2021年4月 90Pages
QYResearch社発行の本調査資料では、成長ホルモン欠乏症治療のグローバル市場（2016年～2027年）について調べ、市場動向、主要企業の市場シェア、種類別市場規模（薬物療法、組換えヒト成長ホルモン、ヒト下垂体抽出物、手術）、用途別市場規模（病院、診療所、在宅ケア）、主要地域別市場規模（北米、ア...

世界のCARD9欠乏症治療市場規模・現状・予測（2021年-2027年）

Global CARD9 Deficiency Treatment Market Size, Status and Forecast 2021-2027
QYR2104Z1109 2021年4月 96Pages
QYResearch社発行の本調査資料では、CARD9欠乏症治療のグローバル市場（2016年～2027年）について調べ、市場動向、主要企業の市場シェア、種類別市場規模（全身性抗真菌性感染症、表面的抗真菌性感染症）、用途別市場規模（病院、クリニック、薬局、その他）、主要地域別市場規模（北米、アメリカ、...

世界のCARD9欠乏症治療市場規模・現状・予測（2021年-2027年）

世界のα1-アンチトリプシン欠乏症治療市場 2021：企業別、地域別、種類・用途別 The Alpha 1 Antitrypsin Deficiency Treatment market report provides a detailed analysis of global market size, regional and country-level market size, segmentation market growth, market share, competitive Landscape, sales analysis, impact of domestic and global market players, value chain optimizati…
世界のアデノシンデアミナーゼ欠損症（ADA）治療市場規模・現状・予測（2021年-2027年） Adenosine deaminase deficiency is an autosomal recessive metabolic disorder that causes immunodeficiency. It occurs in fewer than one in 100,000 live births worldwide. Market Analysis and Insights: Global Adenosine Deaminase Deficiency Treatment Market The global Adenosine Deaminase Deficiency Treat…
世界の第IX因子欠乏症治療市場規模・現状・予測（2021年-2027年） Factor IX (or Christmas factor) is one of the serine proteases of the coagulation system; it belongs to peptidase family S1. Deficiency of this protein causes hemophilia B. In this market study, analysts have estimated the prophylaxis segment to dominate the factor IX deficiency treatment market dur…
世界の成長ホルモン欠乏症治療市場規模・現状・予測（2021年-2027年） Growth hormone deficiency (GHD) is a medical condition characterized by insufficient production of somatropin, a growth hormone, from the anterior pituitary gland which is responsible for the growth and cell reproduction. The primary factor contributing to the growth of global growth hormone deficie…
世界のビタミンD欠乏症治療市場規模・現状・予測（2021年-2027年） Market Analysis and Insights: Global Vitamin D Deficiency Treatment Market The global Vitamin D Deficiency Treatment market size is projected to reach US$ XX million by 2026, from US$ XX million in 2019, at a CAGR of XX% during 2021-2026. With industry-standard accuracy in analysis and high data int…